US Stock MarketDetailed Quotes

Pliant Therapeutics (PLRX)

Watchlist
  • 1.290
  • +0.010+0.78%
Close Jan 16 16:00 ET
  • 1.281
  • -0.009-0.67%
Post 16:11 ET
79.27MMarket Cap-0.45P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Pliant Therapeutics (PLRX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
-83.69%1.58M
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
-83.69%1.58M
--0
Cost of revenue
Gross profit
Operating expense
-54.42%28.27M
-24.81%45.59M
12.49%58.94M
22.96%228.37M
13.36%53.32M
30.05%62.01M
27.46%60.64M
20.64%52.39M
35.68%185.73M
19.49%47.04M
Selling and administrative expenses
-27.55%10.33M
-10.84%13.39M
1.66%15.5M
1.95%59.06M
4.86%14.53M
-7.08%14.26M
3.07%15.02M
7.72%15.25M
45.00%57.93M
-2.79%13.85M
-General and administrative expense
-27.55%10.33M
-10.84%13.39M
1.66%15.5M
1.95%59.06M
4.86%14.53M
-7.08%14.26M
3.07%15.02M
7.72%15.25M
45.00%57.93M
-2.79%13.85M
Research and development costs
-62.44%17.94M
-29.42%32.2M
16.93%43.44M
32.48%169.31M
16.91%38.79M
47.67%47.75M
38.22%45.62M
26.90%37.15M
31.84%127.8M
32.13%33.18M
Operating profit
54.42%-28.27M
24.81%-45.59M
-12.49%-58.94M
-24.01%-228.37M
-13.36%-53.32M
-30.05%-62.01M
-28.13%-60.64M
-24.46%-52.39M
-44.77%-184.15M
-25.77%-47.04M
Net non-operating interest income expense
-53.71%1.97M
-52.10%2.29M
-49.07%2.77M
-20.82%18.06M
-39.47%3.59M
-31.41%4.25M
-22.02%4.79M
19.57%5.44M
488.01%22.81M
153.33%5.93M
Non-operating interest income
-45.73%2.78M
-45.14%3.1M
-39.34%3.57M
-12.42%21.09M
-29.24%4.42M
-21.29%5.13M
-12.42%5.65M
21.08%5.88M
415.55%24.08M
135.19%6.25M
Non-operating interest expense
-7.07%815K
-6.80%809K
79.55%799K
138.67%3.02M
159.81%834K
176.66%877K
172.10%868K
43.09%445K
60.18%1.27M
1.26%321K
Other net income (expense)
Income before tax
54.47%-26.3M
22.48%-43.3M
-19.62%-56.17M
-30.35%-210.3M
-20.98%-49.73M
-39.23%-57.76M
-35.59%-55.85M
-25.05%-46.96M
-30.83%-161.34M
-17.25%-41.11M
Income tax
Net income
54.47%-26.3M
22.48%-43.3M
-19.62%-56.17M
-30.35%-210.3M
-20.98%-49.73M
-39.23%-57.76M
-35.59%-55.85M
-25.05%-46.96M
-30.83%-161.34M
-17.25%-41.11M
Net income continuous Operations
54.47%-26.3M
22.48%-43.3M
-19.62%-56.17M
-30.35%-210.3M
-20.98%-49.73M
-39.23%-57.76M
-35.59%-55.85M
-25.05%-46.96M
-30.83%-161.34M
-17.25%-41.11M
Minority interest income
Net income attributable to the parent company
54.47%-26.3M
22.48%-43.3M
-19.62%-56.17M
-30.35%-210.3M
-20.98%-49.73M
-39.23%-57.76M
-35.59%-55.85M
-25.05%-46.96M
-30.83%-161.34M
-17.25%-41.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
54.47%-26.3M
22.48%-43.3M
-19.62%-56.17M
-30.35%-210.3M
-20.98%-49.73M
-39.23%-57.76M
-35.59%-55.85M
-25.05%-46.96M
-30.83%-161.34M
-17.25%-41.11M
Basic earnings per share
54.74%-0.43
22.83%-0.71
-17.95%-0.92
-26.18%-3.47
-18.84%-0.82
-35.71%-0.95
-31.43%-0.92
-16.42%-0.78
6.46%-2.75
4.17%-0.69
Diluted earnings per share
54.74%-0.43
22.83%-0.71
-17.95%-0.92
-26.18%-3.47
-18.84%-0.82
-35.71%-0.95
-31.43%-0.92
-16.42%-0.78
6.46%-2.75
4.17%-0.69
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 00000000-83.69%1.58M0
Operating revenue --0--0--0--0--0--0--0--0-83.69%1.58M--0
Cost of revenue
Gross profit
Operating expense -54.42%28.27M-24.81%45.59M12.49%58.94M22.96%228.37M13.36%53.32M30.05%62.01M27.46%60.64M20.64%52.39M35.68%185.73M19.49%47.04M
Selling and administrative expenses -27.55%10.33M-10.84%13.39M1.66%15.5M1.95%59.06M4.86%14.53M-7.08%14.26M3.07%15.02M7.72%15.25M45.00%57.93M-2.79%13.85M
-General and administrative expense -27.55%10.33M-10.84%13.39M1.66%15.5M1.95%59.06M4.86%14.53M-7.08%14.26M3.07%15.02M7.72%15.25M45.00%57.93M-2.79%13.85M
Research and development costs -62.44%17.94M-29.42%32.2M16.93%43.44M32.48%169.31M16.91%38.79M47.67%47.75M38.22%45.62M26.90%37.15M31.84%127.8M32.13%33.18M
Operating profit 54.42%-28.27M24.81%-45.59M-12.49%-58.94M-24.01%-228.37M-13.36%-53.32M-30.05%-62.01M-28.13%-60.64M-24.46%-52.39M-44.77%-184.15M-25.77%-47.04M
Net non-operating interest income expense -53.71%1.97M-52.10%2.29M-49.07%2.77M-20.82%18.06M-39.47%3.59M-31.41%4.25M-22.02%4.79M19.57%5.44M488.01%22.81M153.33%5.93M
Non-operating interest income -45.73%2.78M-45.14%3.1M-39.34%3.57M-12.42%21.09M-29.24%4.42M-21.29%5.13M-12.42%5.65M21.08%5.88M415.55%24.08M135.19%6.25M
Non-operating interest expense -7.07%815K-6.80%809K79.55%799K138.67%3.02M159.81%834K176.66%877K172.10%868K43.09%445K60.18%1.27M1.26%321K
Other net income (expense)
Income before tax 54.47%-26.3M22.48%-43.3M-19.62%-56.17M-30.35%-210.3M-20.98%-49.73M-39.23%-57.76M-35.59%-55.85M-25.05%-46.96M-30.83%-161.34M-17.25%-41.11M
Income tax
Net income 54.47%-26.3M22.48%-43.3M-19.62%-56.17M-30.35%-210.3M-20.98%-49.73M-39.23%-57.76M-35.59%-55.85M-25.05%-46.96M-30.83%-161.34M-17.25%-41.11M
Net income continuous Operations 54.47%-26.3M22.48%-43.3M-19.62%-56.17M-30.35%-210.3M-20.98%-49.73M-39.23%-57.76M-35.59%-55.85M-25.05%-46.96M-30.83%-161.34M-17.25%-41.11M
Minority interest income
Net income attributable to the parent company 54.47%-26.3M22.48%-43.3M-19.62%-56.17M-30.35%-210.3M-20.98%-49.73M-39.23%-57.76M-35.59%-55.85M-25.05%-46.96M-30.83%-161.34M-17.25%-41.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 54.47%-26.3M22.48%-43.3M-19.62%-56.17M-30.35%-210.3M-20.98%-49.73M-39.23%-57.76M-35.59%-55.85M-25.05%-46.96M-30.83%-161.34M-17.25%-41.11M
Basic earnings per share 54.74%-0.4322.83%-0.71-17.95%-0.92-26.18%-3.47-18.84%-0.82-35.71%-0.95-31.43%-0.92-16.42%-0.786.46%-2.754.17%-0.69
Diluted earnings per share 54.74%-0.4322.83%-0.71-17.95%-0.92-26.18%-3.47-18.84%-0.82-35.71%-0.95-31.43%-0.92-16.42%-0.786.46%-2.754.17%-0.69
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.11%
Sample Name
Sample Code
 +2.53%
Sample Name
Sample Code
 +2.08%
4
Tempus AI
TEM
+2.05%
5
Block
XYZ
+1.59%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.35%
Sample Name
Sample Code
 +10.03%
Sample Name
Sample Code
 +9.57%
4
Kingsoft Cloud
KC
+7.99%
5
United Microelectronics
UMC
+5.80%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -